Zynex
ZYXI
About: Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Employees: 1,000
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
3% less capital invested
Capital invested by funds: $14.1M [Q1] → $13.7M (-$436K) [Q2]
2.57% less ownership
Funds ownership: 20.07% [Q1] → 17.51% (-2.57%) [Q2]
12% less funds holding
Funds holding: 86 [Q1] → 76 (-10) [Q2]
20% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 25
32% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 31
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
|
RBC Capital
Shagun Singh
|
$3
|
Sector Perform
Maintained
|
15 Jul 2025 |
Financial journalist opinion
Based on 5 articles about ZYXI published over the past 30 days
